Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Douglas W. Mapel"'
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss 1, Pp 1-17 (2019)
Abstract Background Retrospective observational studies may provide real-world evidence about long-acting muscarinic receptor antagonist (LAMA) effectiveness in reducing mortality or COPD-related readmission risk after a COPD hospitalization. Causal
Externí odkaz:
https://doaj.org/article/a6da9812b7a74ca4b2cf9bb25fd0bc8b
Autor:
Douglas W Mapel, Melissa Roberts
Publikováno v:
Southwest Respiratory and Critical Care Chronicles, Vol 3, Iss 10, Pp 1-9 (2015)
Purpose:We conducted a prospective clinical cohort study of 300 established COPD patients randomly recruited from one managed care system to examine how well a battery of spirometry, exercise, and health status measures, including the St. Georges Res
Externí odkaz:
https://doaj.org/article/bf07e8bbc1694bed9e3fa2fd74938d01
Publikováno v:
Drugs in Context, Pp 1-15 (2015)
Background: Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations carry a high risk for early rehospitalization. We wished to identify the basic clinical factors associated with a high risk of rehospitalization, and to
Externí odkaz:
https://doaj.org/article/5d404f7129e9467b9ef66419a95b9d22
Publikováno v:
International Journal of COPD, Vol 2010, Iss default, Pp 1-10 (2009)
Barbara P Yawn1, Douglas W Mapel2, David M Mannino3, Fernando J Martinez4, James F Donohue5, Nicola A Hanania6, Mark Kosinski7, Regina Rendas-Baum7, Matthew Mintz8, Steven Samuels9, Anand A Dalal10, On behalf of the Lung Function Questionnaire Workin
Externí odkaz:
https://doaj.org/article/9d814057ab194110a4eb0c480ec10582
Publikováno v:
International journal of chronic obstructive pulmonary disease. 17
Melissa H Roberts,1 Douglas W Mapel,1,2 Nikhil Ganvir,3 Melanie A Dodd1 1College of Pharmacy, The University of New Mexico, Albuquerque, NM, USA; 2Northern Arizona Pulmonary Associates/Critical Care Consultants of Arizona, Flagstaff, AZ, USA; 3Depart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885bec71f754e2f7c7a2c69d31d3df1f
https://pubmed.ncbi.nlm.nih.gov/35411140
https://pubmed.ncbi.nlm.nih.gov/35411140
Publikováno v:
Journal of comparative effectiveness research. 9(4)
Aim: Quality, real-world comparative effectiveness (CE) studies of asthma and chronic obstructive pulmonary disease therapy efficacy are scarce. We identified and evaluated peer-reviewed CE and appropriate-use evaluations of budesonide/formoterol com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47924adf8b49ec2d9e9283a41b6cd942
https://pubmed.ncbi.nlm.nih.gov/31983228
https://pubmed.ncbi.nlm.nih.gov/31983228
Autor:
Douglas W. Mapel, Todd A. Lee, J F Philip Merrigan, Richard H. Stanford, Arpita Nag, Marjolaine Gauthier-Loiselle, Richard Rosiello, Michael Schatz, Francis Vekeman, Mei Sheng Duh
Publikováno v:
Annals of the American Thoracic Society. 13:1067-1075
Current chronic obstructive pulmonary disease (COPD) exacerbation risk prediction models are based on clinical data not easily accessible to national quality-of-care organizations and payers. Models developed from data sources available to these orga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47d77156a47e4b9ee3a77b95b9566ab
https://doi.org/10.1513/annalsats.201508-493oc
https://doi.org/10.1513/annalsats.201508-493oc
Autor:
Richard H, Stanford, Arpita, Nag, Douglas W, Mapel, Todd A, Lee, Richard, Rosiello, Michael, Schatz, Francis, Vekeman, Marjolaine, Gauthier-Loiselle, J F Philip, Merrigan, Mei Sheng, Duh
Publikováno v:
The American journal of managed care. 24(2)
To develop and validate a predictive model for first severe chronic obstructive pulmonary disease (COPD) exacerbation using health insurance claims data and to validate the risk measure of controller medication to total COPD treatment (controller and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40331d2fd87f461a774c1468b11d2e4e
https://pubmed.ncbi.nlm.nih.gov/29461849
https://pubmed.ncbi.nlm.nih.gov/29461849
Publikováno v:
The American Journal of Medicine. 128:629-637
Purpose Primary care physicians often do not use spirometry to confirm the diagnosis of chronic obstructive pulmonary disease. This project was designed to see how well physicians' impressions about their patients' chronic obstructive pulmonary disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e520bbdebff6dbef0dd60e40289b9d
https://doi.org/10.1016/j.amjmed.2014.12.018
https://doi.org/10.1016/j.amjmed.2014.12.018
Autor:
Matthew E. Borrego, Larry Georgopoulos, Douglas W. Mapel, Dennis W. Raisch, Melissa H. Roberts, David N. van der Goes
Publikováno v:
Drugs-Real World Outcomes
Objective Results from three observational methods for assessing effectiveness of long-acting bronchodilator therapies for reducing severe exacerbations of chronic obstructive pulmonary disease (COPD) were compared: intent-to-treat (ITT), as protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61af27b3d73164a85691e8016541e29
http://europepmc.org/articles/PMC4883193
http://europepmc.org/articles/PMC4883193